Characteristic | Aβ-PET(−)b | Aβ-PET(+)b | P value |
---|---|---|---|
Participants, No. (%) | 164 (82) | 36 (18) | |
Age, years | 66.0 (60.0-69.5) | 70.0 (67.0–73.0) | .0003 |
Female, No. (%) | 110 (67) | 16 (44) | .0185 |
APOE ɛ4, No. (%) | |||
0 alleles | 131 (80) | 17 (47) | .0002 |
1 allele | 29 (18) | 18 (50) | |
2 alleles | 4 (2) | 1 (3) | |
Duration of education, years | 15.0 (12.0–18.0) | 16.0 (10.0–18.0) | .9796 |
FBB-PET, CL | −3.7 (−7.9–1.7) | 34.1 (20.3–57.0) | < .0001 |
MMSE, score | 29 (29–30) | 30 (29–30) | .1321 |
S-FNAME, score | 33.5 (22.0–46.0) | 24.0 (16.0–33.0) | .0013 |
SFN-N composite, score | −0.03 (−0.61–0.65) | −0.88 (−1.05 to −0.22) | < .0001 |
Ventricular volumec,d, mm3 | 24959.5 (19776.4–32028.2) | 29061.4 (21966.7–38034.6) | .1079 |
Hippocampal volumec,d, mm3 | 3606.1 (3421.0–3820.8) | 3581.8 (3284.2–3792.7) | .3611 |
Plasma Aβ40e, pg/ml | 269.3 (243.9–294.2) | 297.0 (267.2–317.6) | .0009 |
Plasma Aβ42e, pg/ml | 70.2 (63.1–77.3) | 63.4 (57.8–72.1) | .0041 |
Plasma Aβ42/Aβ40, ratio | 0.261 (0.244–0.279) | 0.215 (0.203–0.236) | < .0001 |